These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 9284586)

  • 41. [Prevalence of anti-HAV in the Spanish population].
    Carreño García V; González Alonso R; Porres Cubero JC; Ortiz Masllorens F; Martín Calderín F; Hernández Guío C
    Rev Esp Enferm Apar Dig; 1983 Sep; 64(3):187-90. PubMed ID: 6316427
    [No Abstract]   [Full Text] [Related]  

  • 42. [Prevalence of hepatitis A antibodies in polytransfused thalassemic patients].
    Mangiagli A
    Pediatr Med Chir; 1997; 19(6):437-8. PubMed ID: 9595581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The declining pattern of seroepidemiology of hepatitis A virus infection among adolescents in Bangkok, Thailand.
    Poovorawan Y; Vimolkej T; Chongsrisawat V; Theamboonlers A; Chumdermpadetsuk S
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):154-7. PubMed ID: 9322299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Evolution of the prevalence of hepatitis A antibody in Seville].
    Rivera F; Ruiz J; García de Pesquera F
    Aten Primaria; 1998 Feb; 21(2):97-100. PubMed ID: 9608133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Travel-associated hepatitis A: effect of place of residence and country visited.
    Mele A; Sagliocca L; Palumbo F; Stazi MA; Rosmini F; Ferrigno L; Corona R; Osborn J; Gill ON; Pasquini P
    J Public Health Med; 1991 Nov; 13(4):256-9. PubMed ID: 1764281
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spanish Association for the Study of the Liver].
    Bruguera M; Buti M; Diago M; García Bengoechea M; Jara P; Pedreira JD; Ruiz Estremera A
    Med Clin (Barc); 1998 Sep; 111(9):341-6. PubMed ID: 9810537
    [No Abstract]   [Full Text] [Related]  

  • 47. [Sero-epidemiology of hepatitis A. Results obtained in Senegal (Fleuve and Casamance regions) (author's transl)].
    Baylet R; Lemaire JM; Ridet J
    Pathol Biol (Paris); 1981 Apr; 29(4):217-21. PubMed ID: 6262704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decline in anti-HAV prevalence in the Milan area between 1958 and 1992.
    Zanetti AR; Romanò L; Tanzi E; Andreassi A; Pozzi A; Panuccio A; Stroffolini T
    Eur J Epidemiol; 1994 Oct; 10(5):633-5. PubMed ID: 7859866
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changing seroepidemiology of hepatitis A virus infection in Taiwan.
    Hsu HY; Chang MH; Chen DS; Lee CY; Sung JL
    J Med Virol; 1985 Dec; 17(4):297-301. PubMed ID: 3001219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Seasonal factors in the epidemiology of viral hepatitis. Statistical research].
    Rondanelli EG; Gorini P; Moratti R; Azzaretti G
    Minerva Med; 1967 May; 58(43):2002-11. PubMed ID: 6028533
    [No Abstract]   [Full Text] [Related]  

  • 51. [Epidemiological research on human viral hepatitis in the province of Pavia].
    Meloni C; Belloni E; Giorgi A; Marchetti R; Pelissero G; Zecca E; Rondanelli EG; Carosi G; Corridori S; De Franchis R
    Nuovi Ann Ig Microbiol; 1982; 33(4-6):697-724. PubMed ID: 7187498
    [No Abstract]   [Full Text] [Related]  

  • 52. Current seroprevalence of hepatitis A virus infection among kindergarten children and teachers in Taiwan.
    Lin DB; Tsai TP; Yang CC; Wang HM; Yuan SC; Cheng MH; You SL; Chen CJ
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):25-8. PubMed ID: 11023060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prevalence of anti-HAV antibodies (hepatitis A virus) in 18-year-old males from the Florence area].
    Calabri GB; Santini MG; Genovese F; Bambi F; Salvi G; Calabri G
    Pediatr Med Chir; 1999; 21(5 Suppl):219-20. PubMed ID: 10963011
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prevalence of anti-HAV antibodies in selected groups of children].
    Ryszkowska A; Gładysz A; Inglot M; Molin I
    Przegl Epidemiol; 2000; 54(3-4):375-83. PubMed ID: 11349601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seroprevalence of hepatitis A antibodies in travellers at the Edmonton Travellers' Health Clinic--Alberta.
    Kocuipchyk FR; Lightfoot PJ; Stout I; Devine RD
    Can Commun Dis Rep; 1995 Apr; 21(8):65-71. PubMed ID: 7787817
    [No Abstract]   [Full Text] [Related]  

  • 56. [Detection and frequency of inapparent infections in epidemic foci of hepatitis A].
    Benda R; König J; Mankovecký L; Hejná M; Sulcová M; Slezácek J; Kmet P; Machula F; Radovnický V
    Cas Lek Cesk; 1986 Dec; 125(52):1598-603. PubMed ID: 3026631
    [No Abstract]   [Full Text] [Related]  

  • 57. [Is there a shift in the epidemiology of hepatitis A in Mexican children?].
    García-Juárez I; Solórzano Santos F; Alvarez-y-Muñoz MT; Vázquez-Rosales JG
    Rev Invest Clin; 2008; 60(4):292-6. PubMed ID: 18956550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Viral hepatitis C in Basilicata in the years 1992-1993: a retrospective study.
    Squarcione S; Troiano T; Carbini R; Cugno G; D'Amato S
    Ann Ig; 1995; 7(6):439-43. PubMed ID: 8663973
    [No Abstract]   [Full Text] [Related]  

  • 59. [Prevalence of hepatitis A and B in the population of Valdivia: a seroepidemiological study].
    Riedemann S; Hochstein-Mintzel V; Reinhardt G
    Rev Med Chil; 1984 Jul; 112(7):672-4. PubMed ID: 6096951
    [No Abstract]   [Full Text] [Related]  

  • 60. Hepatitis a in Korea: epidemiological shift and call for vaccine strategy.
    Lee D; Cho YA; Park Y; Hwang JH; Kim JW; Kim NY; Lee DH; Lee W; Jeong SH
    Intervirology; 2008; 51(2):70-4. PubMed ID: 18434743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.